54 participants
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-24
- Start Date:
- 2020-03-01
- Completion:
- 2022-08-01
Conditions
- Hepatocellular Carcinoma
Interventions
- DRUG
- PROCEDURE
No Results Yet